Navigation Links
HIV Experts Propose New Approach to Eradicate HIV in Latest Issue of Science
Date:3/5/2009

Tibotec joins other leaders from academia, industry and government in collaboration to fight HIV

YARDLEY, Pa., March 5 /PRNewswire/ -- A group of leading HIV experts call for the exploration of a new approach to treating HIV - one that could ultimately help eradicate the virus - through a collaboration involving academia, industry, government and patient advocates. This new approach to HIV treatment is discussed in a perspective article published in the March 6, 2009 issue of Science.

The article, provocatively titled, "The Challenge of a Cure for HIV Infection," is authored by three academics, Doug Richman, UCSD; David Margolis, UNC; Warner Greene, UCSF; one community advocate, the late Martin Delaney, Project Inform; and two industry scientist leaders, Daria Hazuda, Merck; Roger Pomerantz, Tibotec.

This diverse group came together to set a goal for the next era in HIV therapeutics - drug free remission - and assemble a coordinated initiative to identify potential interventions and a clinical assessment to reach this goal. The initiative, which the authors coined a "collaboratory," aims to accelerate the progress of individual research groups, harness the drug discovery capabilities of industry and utilize the government to coordinate regulatory approaches and mobilize funding.

"A successful vaccine or microbicide still remains a significant challenge in spite of billions of dollars and years of research, and having millions of people on lifelong highly active antiretroviral therapy (HAART) may not be sustainable," said Roger Pomerantz, M.D., FACP, President of Tibotec R&D. "At Tibotec, we have a heritage of partnership and collaboration, and we are committed to forging new approaches with others to develop HIV therapeutics that could finally eradicate the disease."

Envisioning the Post-HAART Era

Since the arrival of HAART more than a decade ago, people diagnosed with HIV have gained a lengthened life expectancy and improved quality of life. Today, patients newly infected with HIV can expect to live 40-50 years as a result of HAART. However, HAART is not the optimal solution for HIV - it requires lifelong therapy, the medication can cause various side effects and the effects of long-term HAART are not yet known. And, if HAART is interrupted, the virus rapidly replicates and the patient's immune system is attacked once more. HAART suppresses the virus, but it is unable to eradicate it completely. As a result, the virus persists in latently infected cells (HIV latency) and other reservoirs. The authors conclude that eradicating the virus from these cells and reservoirs is a crucial approach in the pursuit for therapies that could provide drug free remission, and potentially a cure.

The three academics and two industry scientists who authored the Science article have individually been involved in independent studies of HIV latency and reservoirs, and there has been significant progress in understanding these conditions. However, the authors point out, such discrete studies may be duplicative and slow to build up a complete picture.

"A flexible, collaborative private-public joint venture has the possibility to catalyze progress in the search for therapeutic interventions that can eradicate HIV and result in drug-free remission for HIV patients," said Paul Stoffels, M.D., Company Group Chairman, Johnson & Johnson. "This new approach of 'open innovation' is critical if we are to meet the really big challenges that remain today in the HIV field, such as eradication."

About Tibotec

Tibotec, Inc., based in Yardley PA, is a pharmaceutical research and development company. The Company's main research and development facilities are in Mechelen, Belgium with head office in Cork, Ireland. Tibotec is dedicated to the discovery and development of innovative HIV/AIDS drugs and anti-infectives for diseases of high unmet medical need.

Media Contact: Karen Manson +32 479 89 47 99 (mobile)


'/>"/>
SOURCE Tibotec
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Experts examine causes, treatment and prevention of glaucoma
2. SilverCensus.com Names Consumer Affairs Advocate, Healthcare Experts to Provide Free Educational Support for Seniors
3. Policy experts urge scrutiny of senior tax breaks
4. Interview with GI Experts: Discussions in Clostridium difficile
5. Burn rehabilitation experts at UT Southwestern outline best treatments for post-burn itching
6. Rush University Medical Center experts present latest research findings at AAOS meeting
7. Health experts urge supermarket pharmacies to get smart about free antibiotics
8. Experts Call for FDA Regulation of Tobacco Products
9. Experts in Government, Public Health, Public Policy and Science Outline Blueprint for Reducing Death and Disease From Tobacco in the United States
10. Avon Foundation Convened Breast Cancer Experts in Miami to Address Prevention Strategies at Annual Forum
11. International Panel of Experts Gather for Roundtable Consensus Regarding Multiple Myeloma Related Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... ... March 01, 2017 , ... ... of eating disorders, is pleased to announce the opening of residential services, in ... this week, Aloria Health will accept adult clients for residential treatment. , ...
(Date:3/1/2017)... , ... March 01, 2017 , ... Hennessey Performance (HPE) today announced its VelociRaptor 600 ... Ford EcoBoost 3.5L twin turbo V6 engine from 450 bhp and 510 lb-ft of torque ... a 0-60 mph time of just 4.2 seconds while running down the ¼ mile in ...
(Date:3/1/2017)... ... March 01, 2017 , ... Both incentives ... Supplemental Nutrition Assistance Program (SNAP) can reduce food insecurity. Findings are presented in ... the American Journal of Preventive Medicine . , Researchers examined data from two ...
(Date:3/1/2017)... ... March 01, 2017 , ... ... the release of its 2017 update to Compass, the popular online learning ... advisors. , Suitable for standardizing both new-hire on-boarding and annual competency-validation, Compass ...
(Date:3/1/2017)... ... 01, 2017 , ... Award-winning medical group Allied Anesthesia today announced that, as ... nations, averaging more than one trip per year since 1998. Char was named the ... features the details of his charitable work. Char has been an Allied Anesthesiologist since ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... , March 1, 2017  Global biotherapeutics leader ... completed the largest ever Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) ... nd T reatment with H izentra ® ... demonstrate the efficacy, safety and tolerability of two different ... (Immune Globulin Subcutaneous [Human]), compared with placebo, in ...
(Date:3/1/2017)... -- The Welch Foundation, one of the nation,s largest sources ... Drs. Neal M. Alto and Delia ... Norman Hackerman Award in Chemical Research. Both ... significant scientific discoveries at early stages of their careers. ... of the Hackerman Award that two recipients have been ...
(Date:3/1/2017)... Mar 01, 2017 Research and Markets has ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... drug pricing data and benchmarks in the global Acute Myeloid Leukemia ... of your competitor drugs and find out how the marketed products ...
Breaking Medicine Technology: